Skip to main content
Have a personal or library account? Click to login
The Global, Regional, and National Burden of Tracheal, Bronchus, and Lung Cancer Caused by Smoking: An Analysis Based on the Global Burden of Disease Study 2021 Cover

The Global, Regional, and National Burden of Tracheal, Bronchus, and Lung Cancer Caused by Smoking: An Analysis Based on the Global Burden of Disease Study 2021

Open Access
|Dec 2024

References

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229263. doi:10.3322/caac.21834. PMID: 38572751.
  2. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD‑3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‑based registries in 71 Countries. Lancet. 2018;391:10231075. doi:10.1016/S0140-6736(17)33326-3. PMID: 29395269.
  3. Liu C, Shi J, Wang H, et al. Population‑level economic burden of lung cancer in China: Provisional prevalence‑based estimations, 2017–2030. Chin J Cancer Res. 2021;33:7992. doi:10.21147/j.issn.1000-9604.2021.01.09. PMID: 33707931.
  4. Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: Current status and future trends. Nat Rev Clin Oncol. 2023;20:624639. doi:10.1038/s41571-023-00798-3. PMID: 37479810.
  5. Li C, Lei S, Ding L, et al. Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023;136:15831590. doi:10.1097/CM9.0000000000002529. PMID: 37027426.
  6. Ordóñez‑Mena JM, Schöttker B, Mons U, et al. Quantification of the smoking‑associated cancer risk with rate advancement periods: Meta‑analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med. 2016;14:62. doi:10.1186/s12916-016-0607-5. PMID: 27044418.
  7. Yang X, Zhang T, Zhang X, Chu C, Sang S. Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990–2019. Environ Res. 2022;204:112023. doi:10.1016/j.envres.2021.112023. PMID: 34520750.
  8. Deng Y, Zhao P, Zhou L, et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: A population‑based study. J Hematol Oncol. 2020;13:98. doi:10.1186/s13045-020-00915-0. PMID: 32690044.
  9. Safiri S, Sohrabi M‑R, Carson‑Chahhoud K, et al. Burden of tracheal, bronchus, and lung cancer and its attributable risk factors in 204 Countries and territories, 1990–2019. J Thorac Oncol. 2021;16:945959. doi:10.1016/j.jtho.2021.03.030. PMID: 33866016.
  10. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability‑adjusted life‑years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:21332161. doi:10.1016/S0140-6736(24)00757-8. PMID: 38642570.
  11. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:21622203. doi:10.1016/S0140-6736(24)00933-4. PMID: 38762324.
  12. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:21002132. doi:10.1016/S0140-6736(24)00367-2. PMID: 38582094.
  13. Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: The GATHER statement. Lancet. 2016;388:e19e23. doi:10.1016/S0140-6736(16)30388-9. PMID: 27371184.
  14. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010‑19: A systematic analysis for the global burden of disease study 2019. Lancet. 2022;400:563591. doi:10.1016/S0140-6736(22)01438-6. PMID: 35988567.
  15. Ping S, Yu C, Yin L, et al. Global, regional, and national burden of female cancers in women of child‑bearing age, 1990–2021: Analysis of data from the global burden of disease study 2021. EClinicalMedicine. 2024:74:102713. doi:10.1016/j.eclinm.2024.102713. PMID: 39050105.
  16. GBD 2021 Carbon Monoxide Poisoning Collaborators. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: Results from the global burden of disease study 2021. Lancet Public Health. 2023;8:e839e849. doi:10.1016/S2468-2667(23)00185-8. PMID: 37813118.
  17. Liu S, Lv Y, Zhang Y, Suo H, Wang F, Gao S. Global trends and burden of stroke attributable to particulate matter pollution from 1990 to 2019. Ecotoxicol Environ Saf. 2024;274:116205. doi:10.1016/j.ecoenv.2024.116205. PMID: 38503105.
  18. Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990–2019. JAMA Pediatr. 2022;176:787796. doi:10.1001/jamapediatrics.2022.1622. PMID: 35639401.
  19. Bishara AJ, Hittner JB. Testing the significance of a correlation with nonnormal data: Comparison of Pearson, Spearman, transformation, and resampling approaches. Psychol Methods. 2012;17:399417. doi:10.1037/a0028087. PMID: 22563845.
  20. Zhang K, Kan C, Han F, et al. Global, regional, and national epidemiology of diabetes in children from 1990 to 2019. JAMA Pediatr. 2023;177:837846. doi:10.1001/jamapediatrics.2023.2029. PMID: 37399036.
  21. Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409436. doi:10.3322/caac.21731. PMID: 35736631.
  22. Jokhadze N, Das A, Dizon DS. Global cancer statistics: A healthy population relies on population health. CA Cancer J Clin. 2024;74:224226. doi:10.3322/caac.21838. PMID: 38572764.
  23. Fu X, Qin P, Li F, et al. The inter‑link of ageing, cancer and immunity: Findings from real‑world retrospective study. Immun Ageing. 2023;20:75. doi:10.1186/s12979-023-00399-9. PMID: 38102684.
  24. Yach D. The origins, development, effects, and future of the WHO framework convention on Tobacco control: A personal perspective. Lancet. 2014;383:17711779. doi:10.1016/S0140-6736(13)62155-8. PMID: 24461287.
  25. Bialous S, Da Costa E, Silva VL. Where next for the WHO framework convention on Tobacco control? Tob Control. 2022;31:183186. doi:10.1136/tobaccocontrol-2021-056545. PMID: 35241586.
  26. Sheikh M, Mukeriya A, Shangina O, Brennan P, Zaridze D. Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: A prospective cohort study. Ann Intern Med. 2021;174:12321239. doi:10.7326/M21-0252. PMID: 34310171.
  27. Katanoda K, Jiang Y, Park S, Lim MK, Qiao Y‑L, Inoue M. Tobacco control challenges in East Asia: Proposals for change in the world’s largest epidemic region. Tob Control. 2014;23:359368. doi:10.1136/tobaccocontrol-2012-050852. PMID: 23596197.
  28. Appau A, Drope J, Labonté R, Stoklosa M, Lencucha R. Disentangling regional trade agreements, trade flows and tobacco affordability in sub‑Saharan Africa. Global Health. 2017;13:81. doi:10.1186/s12992-017-0305-x. PMID: 29137678.
  29. Chido‑Amajuoyi OG, Fueta P, Mantey D. Age at smoking initiation and prevalence of cigarette use among youths in Sub‑Saharan Africa, 2014–2017. JAMA Netw Open. 2021;4:e218060. doi:10.1001/jamanetworkopen.2021.8060. PMID: 33961039.
  30. Husain MJ, English LM, Ramanandraibe N. An overview of tobacco control and prevention policy status in Africa. Prev Med. 2016;91S:S16S22. PMID:26876626. doi:10.1016/j.ypmed.2016.02.017.
  31. Jiang H, Livingston M, Room R, Gan Y, English D, Chenhall R. Can public health policies on alcohol and tobacco reduce a cancer epidemic? Australia’s experience. BMC Med. 2019;17:213. doi:10.1186/s12916-019-1453-z. PMID: 31771596.
  32. King BA, Ahluwalia IB, Bacelar Gomes A, Fong GT. Combating the tobacco epidemic in North America: Challenges and opportunities. Tob Control. 2022;31:169172. doi:10.1136/tobaccocontrol-2021-056812. PMID: 34452985.
  33. Stefler D, Murphy M, Irdam D, et al. Smoking and mortality in eastern europe: Results from the PrivMort retrospective cohort study of 177 376 Individuals. Nicotine Tob Res. 2018;20:749754. doi:10.1093/ntr/ntx122. PMID: 28575492.
  34. Santucci C, Patel L, Malvezzi M, et al. Persisting cancer mortality gap between western and eastern Europe. Eur J Cancer. 2022;165:112. doi:10.1016/j.ejca.2022.01.007. PMID: 35189536.
  35. Vrdoljak E, Bodoky G, Jassem J, et al. Cancer control in central and eastern europe: Current situation and recommendations for improvement. Oncologist. 2016;21:11831890. doi:10.1634/theoncologist.2016-0137. PMID: 27401890.
  36. Yang G, Wang Y, Wu Y, Yang J, Wan X. The road to effective tobacco control in China. Lancet. 2015;385:10191028. doi:10.1016/S0140-6736(15)60174-X. PMID: 25784349.
  37. Chan KH, Xiao D, Zhou M, Peto R, Chen Z. Tobacco control in China. Lancet Public Health. 2023;8:e1006e1015. doi:10.1016/S2468-2667(23)00242-6. PMID: 38000880.
  38. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio‑demographic inequalities in stage of cancer diagnosis: Evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol. 2013;24:843850. doi:10.1093/annonc/mds526. PMID: 23149571.
  39. Palipudi KM, Gupta PC, Sinha DN, et al. Social determinants of health and tobacco use in thirteen low and middle income countries: Evidence from Global Adult Tobacco Survey. PLoS One. 2012;7:e33466. doi:10.1371/journal.pone.0033466. PMID: 22438937.
  40. Fucito LM, Czabafy S, Hendricks PS, et al. Pairing smoking‑cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer. 2016;122:11501159. doi:10.1002/cncr.29926. PMID: 26916412.
  41. Ranabhat CL, Kim C‑B, Park MB, Jakovljevic MM. Situation, impacts, and future challenges of tobacco control policies for youth: An explorative systematic policy review. Front Pharmacol. 2019;10:981. doi:10.3389/fphar.2019.00981. PMID: 31551784.
  42. Racovita M, Wheeler E, Wait S, et al. The need for a comprehensive and integrated approach to lung cancer policy in Europe. Eur J Cancer. 2022;175:5459. doi:10.1016/j.ejca.2022.08.001. PMID: 36088672.
  43. Soma T, Nagata M. Immunosenescence, inflammaging, and lung senescence in asthma in the elderly. Biomolecules. 2022;12:1456. doi:10.3390/biom12101456. PMID: 36291665.
  44. Gould MK. Lung cancer screening and elderly adults: Do we have sufficient evidence? Ann Intern Med. 2014;161:672673. doi:10.7326/M14-2006. PMID: 25199784.
  45. Bottorff JL, Haines‑Saah R, Kelly MT, et al. Gender, smoking and tobacco reduction and cessation: a scoping review. Int J Equity Health. 2014;13:114. doi:10.1186/s12939-014-0114-2. PMID: 25495141.
  46. Lancaster HL, Heuvelmans MA, Oudkerk M. Low‑dose computed tomography lung cancer screening: Clinical evidence and implementation research. J Intern Med. 2022;292:6880. doi:10.1111/joim.13480. PMID: 35253286.
  47. Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ. Lung cancer screening. Lancet. 2023;401:390408. doi:10.1016/S0140-6736(22)01694-4. PMID: 36563698.
  48. Paraje G, Flores Muñoz M, Wu DC, Jha P. Reductions in smoking due to ratification of the Framework Convention for Tobacco Control in 171 Countries. Nat Med. 2024;30:683689. doi:10.1038/s41591-024-02806-0. PMID: 38321222.
DOI: https://doi.org/10.5334/aogh.4572 | Journal eISSN: 2214-9996
Language: English
Submitted on: Oct 3, 2024
Accepted on: Nov 22, 2024
Published on: Dec 5, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Jingting Zhang, Jincheng Tang, Renyi Yang, Siqin Chen, Huiying Jian, Puhua Zeng, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.